Clinical characteristics and surgical treatment for breast cancer patients with liver metastases        JIANG Jun, CHAI Fan. Breast Disease Center, Southwest Hospital, the Third Military Medical University, Chongqing 400038， China
Corresponding author：JIANG Jun, E-mail：jcbd@medmail.com.cn
Abstract    Liver is one of the common metastatic sites for breast cancer. Breast cancer patients with liver metastases (BCLM) are often insensitive to traditional therapy and have poor prognosis. Liver resection is generally adopted if the lesion is localized, which has made BCLM obtain a better outcome. However, it still need to be supported by more large-scale clinical data and evidence, especially for standard operation indication, method and combined modality therapy. Minimally invasive surgery, such as radio frequency ablation (RFA) and laser-induced interstitial thermotherapy (LITT), could provide extra options for BCLM with small tumors, but both have some clinical limitations and still need further clinical study to confirm the curative effects. Surgical treatments for BCLM with comparatively large or multiple tumors are still under exploration. Systemic treatment combined with proper surgical process can improve BCLM prognosis.